mAbs (monoclonal antibodies) are a type of biopharmaceutical drug produced through recombinant DNA technology. Before they can be released for use, mAbs undergo a series of final product release testing to ensure their quality, safety, and efficacy.
The final product release testing includes various assays that assess the product's purity, potency, identity, and stability. These assays include:
Identity Testing: This testing confirms the identity of the mAbs by comparing the product with a reference standard.
Purity Testing: This testing determines the purity of the mAbs by measuring the amount of impurities such as host cell proteins, DNA, and other contaminants.
Potency Testing: This testing evaluates the ability of the mAbs to bind to the target antigen and elicit the desired response.
Sterility Testing: This testing ensures that the mAbs are free from any microbial contamination.
Endotoxin Testing: This testing determines the level of endotoxins present in the mAbs, which can cause adverse reactions in patients.
Stability Testing: This testing assesses the stability of the mAbs over time to ensure that they retain their efficacy and do not degrade.
The final product release testing is conducted according to regulatory guidelines and standards established by regulatory agencies such as the FDA and EMA. Once the mAbs have successfully passed all the final product release testing, they are released for use in clinical trials or for commercial distribution.
ALL Chemistry Inc. is a leading provider of comprehensive biopharmaceutical testing services. We specialize in monoclonal antibody (mAbs) final product release testing, ensuring that your products meet the highest standards of quality and safety.
At ALL Chemistry Inc., we have the expertise and experience needed to perform a wide range of mAbs final product release testing services. Our team of highly trained scientists and technicians use state-of-the-art equipment and techniques to ensure accurate and reliable results.
We offer a comprehensive range of mAbs final product release testing services, including:
Identity testing
Purity testing
Potency testing
Safety testing
Our services are designed to meet the requirements of global regulatory agencies, including the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan.
At ALL Chemistry Inc., we are committed to providing our clients with the highest quality mAbs final product release testing services. We understand the importance of timely and accurate results, and we work closely with our clients to ensure that their products meet all regulatory requirements.
We are dedicated to continuous improvement and innovation, and we invest heavily in research and development to ensure that our services remain at the forefront of the industry.
If you are in need of mAbs final product release testing services, look no further than ALL Chemistry Inc. Contact us today to learn more about our services and how we can help ensure the quality and safety of your products.
+1 609 531 0668
STE 104 Marlton , NJ 08053, USA